White House Withdraws FDA Nominee Heidi Overton After Senate GOP Backpedals
Heidi Overton's FDA nomination was pulled by the White House after wavering Senate Republican support and reported tensions with RFK Jr.
POLICY WIRE — Washington, D.C., U.S. — The White House has officially withdrawn its nomination of Dr. Heidi Overton to serve as the next Commissioner of the Food and Drug Administration. This decision follows significant instability in Republican Senate support for her candidacy.
Multiple news outlets, including AP News and The New York Times, confirmed the White House’s move to pull the nominee. The withdrawal appears to be a direct response to lukewarm backing from key legislative figures.
CNN reported that the decision came amid increased opposition from senators and a notably chilly dynamic between Overton and Administration official RFK Jr. The Guardian and CNBC also cited sources indicating that Trump dropped the pick due to these interpersonal and political hurdles.
This latest development underscores the difficulty in securing controversial agency confirmations in the current political landscape. The FD A commissioner role remains vacant as the White House seeks a new potential candidate.
Reporting by Policy-Wire (PW)



